By Debdeep Gupta | 11 Jul, 2024
Glenmark Life drops 4% on Glenmark Pharma's plans to exit via OFS
Shares of Glenmark Life Sciences slumped as much as nearly 4 percent on July 11, a day after Glenmark Pharma's board greenlit the company's plans to offload a 7.84 percent stake in the former through an offer for sale.With this OFS, Glenmark Pharma will completely exit Glenmark Life Sciences. The floor price for the OFS is fixed at Rs 810 per share, representing a 7.5 percent discount to the previ...
Live Comments
SHIVSHANKAR 2022-07-22 13:35:47
IPO KA SETTLEMENT CHAL RAHA HAI...YOU CANT UNDERSTAND...BUT CUNNING MANAGEMENT DO IT VERY SMARTLY....SEE MARKSAN.... SAME GROUP... BUYBACK LOLIPOP...
Login & Reply Like(0) Dislike(0) Repost Spam